{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:00:26Z","timestamp":1777417226895,"version":"3.51.4"},"reference-count":61,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DICP"],"published-print":{"date-parts":[[1991,6]]},"abstract":"<jats:p>Viral hepatitis is second to gonorrhea as the most commonly reported infectious disease in the US. Hepatitis B accounts for the majority of viral hepatitis cases. Fortunately, the disease is self-limiting and frequently resolves completely with minimal complications; however, a significant number of individuals may experience long-term sequelae. Research utilizing genetic engineering has led to the development of yeast-derived recombinant DNA (YDR) hepatitis vaccines\u2014a significant advancement in the control and prevention of hepatitis B. The recombinant process allows production of unlimited quantities of vaccine at considerably lower cost and without the potential threat of blood-borne illness. Clinical trials in various high-risk populations have demonstrated the effectiveness and safety of YDR vaccines. However, questions regarding optimal regimen and the need for periodic revaccination remain unanswered. Persons at risk should be adequately vaccinated against hepatitis B.<\/jats:p>","DOI":"10.1177\/106002809102500611","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T12:06:42Z","timestamp":1485173202000},"page":"617-627","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic Advances in the Prevention of Hepatitis B: Yeast-Derived Recombinant Hepatitis B Vaccines"],"prefix":"10.1177","volume":"25","author":[{"given":"Mark W.","family":"Garrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danial E.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1991,6,1]]},"reference":[{"key":"bibr-bibr1-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90524-X"},{"key":"bibr-bibr2-106002809102500611","first-page":"1","volume":"39","author":"Centers for Disease Control","year":"1990","journal-title":"MMWR"},{"key":"bibr-bibr3-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90209-5"},{"key":"bibr-bibr4-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8545(21)00413-7"},{"key":"bibr-bibr5-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1989.11700582"},{"key":"bibr-bibr6-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197311292892203"},{"key":"bibr-bibr7-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90206-2"},{"key":"bibr-bibr8-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440090052025"},{"key":"bibr-bibr9-106002809102500611","first-page":"538","volume-title":"The biologic and clinical basis of infectious diseases","author":"Berlin BS","year":"1985","edition":"3"},{"key":"bibr-bibr10-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008023230503"},{"key":"bibr-bibr11-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90221-7"},{"key":"bibr-bibr12-106002809102500611","volume-title":"Engerix-B","author":"Product Information","year":"1989"},{"key":"bibr-bibr13-106002809102500611","volume-title":"Recombivax HB","author":"Product Information","year":"1988"},{"key":"bibr-bibr14-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90528-7"},{"key":"bibr-bibr15-106002809102500611","first-page":"83","volume":"63","author":"Hauser P","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr16-106002809102500611","first-page":"1031","volume-title":"Viral hepatitis and liver disease","author":"Hauser P","year":"1988"},{"key":"bibr-bibr17-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(86)92563-6"},{"key":"bibr-bibr18-106002809102500611","first-page":"S14","volume":"46","author":"Kapusnik-Uner JE","year":"1989","journal-title":"Am J Hosp Pharm"},{"key":"bibr-bibr19-106002809102500611","first-page":"15","volume":"25","author":"Goilav C","year":"1990","journal-title":"Hosp Form"},{"key":"bibr-bibr20-106002809102500611","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/pgmj.63.736.143","volume":"63","author":"Laukamm-Josten U","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr21-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90219-C"},{"key":"bibr-bibr22-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90529-9"},{"key":"bibr-bibr23-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390190090026"},{"key":"bibr-bibr24-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420220092033"},{"key":"bibr-bibr25-106002809102500611","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/pgmj.63.736.159","volume":"63","author":"Cadranel S","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr26-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90237-G"},{"key":"bibr-bibr27-106002809102500611","first-page":"S52","volume":"8","author":"Vandamme P","year":"1990","journal-title":"Vaccine"},{"key":"bibr-bibr28-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.2.332"},{"key":"bibr-bibr29-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290407"},{"key":"bibr-bibr30-106002809102500611","first-page":"151","volume":"63","author":"Giammanco G","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr31-106002809102500611","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/pgmj.63.736.121","volume":"63","author":"Just M","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr32-106002809102500611","first-page":"161","volume":"63","author":"Crovari P","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr33-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90217-A"},{"key":"bibr-bibr34-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0196-6553(89)90213-7"},{"key":"bibr-bibr35-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410240105040"},{"key":"bibr-bibr36-106002809102500611","first-page":"1068","volume-title":"Viral hepatitis and liver disease","author":"Heijtink RA","year":"1988"},{"key":"bibr-bibr37-106002809102500611","first-page":"1071","volume-title":"Viral hepatitis and liver disease","author":"Crovari P","year":"1988"},{"key":"bibr-bibr38-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800054625"},{"key":"bibr-bibr39-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410120080031"},{"key":"bibr-bibr40-106002809102500611","unstructured":"Buchbinder S, Lifson A, Hessol N., Should HIV seropositives receive hepatitis B vaccine (abstract)? 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston, TX; September, 1989: 283."},{"key":"bibr-bibr41-106002809102500611","unstructured":"Safary A, Boscia J, Moonsammy G, Andre F. Anti-HBs responses to hepatitis B vaccination in anti-HIV negative and positive homosexual men and parenteral drug users (abstract). 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston, TX; September, 1989: 132."},{"key":"bibr-bibr42-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03370160055008"},{"key":"bibr-bibr43-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909143211103"},{"key":"bibr-bibr44-106002809102500611","first-page":"165","volume":"43","author":"Puoti C","year":"1987","journal-title":"Prog Med (Rome)"},{"key":"bibr-bibr45-106002809102500611","first-page":"399","volume":"76","author":"Hellgren TE","year":"1989","journal-title":"J Fla Med Assoc"},{"key":"bibr-bibr46-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050605"},{"key":"bibr-bibr47-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(88)90138-7"},{"key":"bibr-bibr48-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)93009-2"},{"key":"bibr-bibr49-106002809102500611","first-page":"129","volume":"63","author":"Ambrosch F","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr50-106002809102500611","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/pgmj.63.737.169","volume":"63","author":"Andre FE","year":"1987","journal-title":"Postgrad Med J"},{"key":"bibr-bibr51-106002809102500611","first-page":"1025","volume-title":"Viral hepatitis and liver disease","author":"Andre FE","year":"1988"},{"key":"bibr-bibr52-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90218-B"},{"key":"bibr-bibr53-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90222-8"},{"key":"bibr-bibr54-106002809102500611","first-page":"789","volume":"46","author":"Mundo F","year":"1989","journal-title":"Curr Ther Res"},{"key":"bibr-bibr55-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90397-1"},{"key":"bibr-bibr56-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(88)90173-9"},{"key":"bibr-bibr57-106002809102500611","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.5.766"},{"key":"bibr-bibr58-106002809102500611","unstructured":"Safary A, Boscia J, Moonsammy G, Andre F. An accelerated dosing schedule of hepatitis B vaccination for those needing rapid protection (abstract). 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston, TX; September, 1989: 133."},{"key":"bibr-bibr59-106002809102500611","unstructured":"Bruguera M, Rodicio J, Esteban-Mur R., Anti-HBs responses of two four-dose hepatitis B vaccination schedules in hemodialysis patients (abstract). 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston, TX; September, 1989: 132."},{"key":"bibr-bibr60-106002809102500611","first-page":"25","volume":"25","author":"Bush L","year":"1990","journal-title":"Hosp Form"},{"key":"bibr-bibr61-106002809102500611","unstructured":"Cardinale V, ed. Drug topics red book. Oradell, NJ: Medical Economics, 1990: 284, 344, 581."}],"container-title":["DICP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809102500611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809102500611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:04:07Z","timestamp":1777374247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002809102500611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["10.1177\/106002809102500611"],"URL":"https:\/\/doi.org\/10.1177\/106002809102500611","relation":{},"ISSN":["1042-9611"],"issn-type":[{"value":"1042-9611","type":"print"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}